The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity of ERY001 (erythrocyte encapsulated l-asparaginase) and native l-asparaginase (L-ASP) in combination with COOPRALL regimen in phase III randomized trial in patients with relapsed acute lymphoblastic leukemia (ALL).
 
Yves Bertrand
Honoraria - ERYTECH Pharma
Consulting or Advisory Role - ERYTECH Pharma
 
Andre Baruchel
No Relationships to Disclose
 
Xavier G. Thomas
Honoraria - ERYTECH Pharma
Travel, Accommodations, Expenses - ERYTECH Pharma
 
Nicolas Blin
No Relationships to Disclose
 
Emmanuelle Tavernier Tardy
No Relationships to Disclose
 
Yves Perel
No Relationships to Disclose
 
Norbert Vey
No Relationships to Disclose
 
Virginie Gandemer
No Relationships to Disclose
 
Victoria Cacheux
No Relationships to Disclose
 
Francoise Mazingue
No Relationships to Disclose
 
Emmanuel Raffoux
No Relationships to Disclose
 
Genevieve Plat
No Relationships to Disclose
 
Maryline Poiree
No Relationships to Disclose
 
Jean-Louis Stephan
No Relationships to Disclose
 
Anne Auvrignon
No Relationships to Disclose
 
Dominique Plantaz
No Relationships to Disclose
 
Isabelle Pellier
No Relationships to Disclose
 
Cecile Bonin
Employment - ERYTECH Pharma
 
Iman El-Hariry
Consulting or Advisory Role - Azur Pharma (Inst)
 
Alina Ferster
No Relationships to Disclose